Drug-induced mitochondrial dysfunction and cardiotoxicity
Top Cited Papers
- 1 November 2015
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 309 (9), H1453-H1467
- https://doi.org/10.1152/ajpheart.00554.2015
Abstract
Mitochondria has an essential role in myocardial tissue homeostasis; thus deterioration in mitochondrial function eventually leads to cardiomyocyte and endothelial cell death and consequent cardiovascular dysfunction. Several chemical compounds and drugs have been known to directly or indirectly modulate cardiac mitochondrial function, which can account both for the toxicological and pharmacological properties of these substances. In many cases, toxicity problems appear only in the presence of additional cardiovascular disease conditions or develop months/years following the exposure, making the diagnosis difficult. Cardiotoxic agents affecting mitochondria include several widely used anticancer drugs [anthracyclines (Doxorubicin/Adriamycin), cisplatin, trastuzumab (Herceptin), arsenic trioxide (Trisenox), mitoxantrone (Novantrone), imatinib (Gleevec), bevacizumab (Avastin), sunitinib (Sutent), and sorafenib (Nevaxar)], antiviral compound azidothymidine (AZT, Zidovudine) and several oral antidiabetics [e.g., rosiglitazone (Avandia)]. Illicit drugs such as alcohol, cocaine, methamphetamine, ecstasy, and synthetic cannabinoids (spice, K2) may also induce mitochondria-related cardiotoxicity. Mitochondrial toxicity develops due to various mechanisms involving interference with the mitochondrial respiratory chain (e.g., uncoupling) or inhibition of the important mitochondrial enzymes (oxidative phosphorylation, Szent-Györgyi-Krebs cycle, mitochondrial DNA replication, ADP/ATP translocator). The final phase of mitochondrial dysfunction induces loss of mitochondrial membrane potential and an increase in mitochondrial oxidative/nitrative stress, eventually culminating into cell death. This review aims to discuss the mechanisms of mitochondrion-mediated cardiotoxicity of commonly used drugs and some potential cardioprotective strategies to prevent these toxicities.Keywords
Funding Information
- NIAAA Intramural Research
This publication has 144 references indexed in Scilit:
- Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of TroglitazoneJournal of Proteome Research, 2013
- Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent MannerJournal of the American College of Cardiology, 2012
- Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathyFree Radical Biology & Medicine, 2012
- Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryFree Radical Biology & Medicine, 2011
- Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: Mitochondria as the major targetBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: Role of insulin signaling and ER stressJournal of Molecular and Cellular Cardiology, 2008
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Pharmacological Inhibition of CB1Cannabinoid Receptor Protects Against Doxorubicin-Induced CardiotoxicityJournal of the American College of Cardiology, 2007
- Simple quantitative detection of mitochondrial superoxide production in live cellsBiochemical and Biophysical Research Communications, 2007
- Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell deathNature, 2005